Sfoglia per Autore
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: A multi-institutional study of adult patients by ILROG
2020-01-01 Binkley M.S.; Shahzad Rauf M.; Milgrom S.A.; Pinnix C.C.; Tsang R.; Dickinson M.; Ng A.K.; Roberts K.B.; Gao S.; Balogh A.; Ricardi U.; Levis M.; Casulo C.; Stolten M.; Specht L.; Plastaras J.P.; Wright C.; Kelsey C.R.; Brady J.L.; George Mikhaeel N.; Hoppe B.S.; Terezakis S.A.; Picardi M.; Pepa R.D.; Kirova Y.; Akhtar S.; Maghfoor I.; Koenig J.L.; Jackson C.; Song E.; Sehgal S.; Advani R.H.; Natkunam Y.; Constine L.S.; Eich H.T.; Wirth A.; Hoppe R.T.
Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines
2020-01-01 Wirth A.; Mikhaeel N.G.; Aleman B.M.P.; Pinnix C.C.; Constine L.S.; Ricardi U.; Illidge T.M.; Eich H.T.; Hoppe B.S.; Dabaja B.; Ng A.K.; Kirova Y.; Berthelsen A.K.; Dieckmann K.; Yahalom J.; Specht L.
ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
2020-01-01 Yahalom J.; Dabaja B.S.; Ricardi U.; Ng A.; Mikhaeel N.G.; Vogelius I.R.; Illidge T.; Qi S.; Wirth A.; Specht L.
Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group
2021-01-01 Qi S.-N.; Li Y.-X.; Specht L.; Oguchi M.; Tsang R.; Ng A.; Suh C.-O.; Ricardi U.; Mac Manus M.; Dabaja B.; Yahalom J.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: A multi-institutional study of adult patients by ILROG | 2020 | Binkley M.S.; Shahzad Rauf M.; Milgrom S.A.; Pinnix C.C.; Tsang R.; Dickinson M.; Ng A.K.; Roberts K.B.; Gao S.; Balogh A.; Ricardi U.; Levis M.; Casulo C.; Stolten M.; Specht L.; Plastaras J.P.; Wright C.; Kelsey C.R.; Brady J.L.; George Mikhaeel N.; Hoppe B.S.; Terezakis S.A.; Picardi M.; Pepa R.D.; Kirova Y.; Akhtar S.; Maghfoor I.; Koenig J.L.; Jackson C.; Song E.; Sehgal S.; Advani R.H.; Natkunam Y.; Constine L.S.; Eich H.T.; Wirth A.; Hoppe R.T. | |
| Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines | 2020 | Wirth A.; Mikhaeel N.G.; Aleman B.M.P.; Pinnix C.C.; Constine L.S.; Ricardi U.; Illidge T.M.; Eich H.T.; Hoppe B.S.; Dabaja B.; Ng A.K.; Kirova Y.; Berthelsen A.K.; Dieckmann K.; Yahalom J.; Specht L. | |
| ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic | 2020 | Yahalom J.; Dabaja B.S.; Ricardi U.; Ng A.; Mikhaeel N.G.; Vogelius I.R.; Illidge T.; Qi S.; Wirth A.; Specht L. | |
| Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group | 2021 | Qi S.-N.; Li Y.-X.; Specht L.; Oguchi M.; Tsang R.; Ng A.; Suh C.-O.; Ricardi U.; Mac Manus M.; Dabaja B.; Yahalom J. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile